These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26712509)

  • 1. Considerations in the Use of Stimulants in Sport.
    Reardon CL; Factor RM
    Sports Med; 2016 May; 46(5):611-7. PubMed ID: 26712509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective.
    Garner AA; Hansen AA; Baxley C; Ross MJ
    Sports Med; 2018 Mar; 48(3):507-512. PubMed ID: 29198023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit hyperactivity disorder, CNS stimulants and sport.
    Hickey G; Fricker P
    Sports Med; 1999 Jan; 27(1):11-21. PubMed ID: 10028130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder.
    Pujalte GGA; Maynard JR; Thurston MJ; Taylor WC; Chauhan M
    Clin J Sport Med; 2019 May; 29(3):245-256. PubMed ID: 29189334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.
    Putukian M; Kreher JB; Coppel DB; Glazer JL; McKeag DB; White RD
    Clin J Sport Med; 2011 Sep; 21(5):392-401. PubMed ID: 21892014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder in sport: a review.
    Corrigan B
    Int J Sports Med; 2003 Oct; 24(7):535-40. PubMed ID: 12968213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
    Mohammadi M; Akhondzadeh S
    Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS stimulant controversies.
    Levy F
    Aust N Z J Psychiatry; 1989 Dec; 23(4):497-502. PubMed ID: 2575372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete.
    Conant-Norville DO; Tofler IR
    Clin Sports Med; 2005 Oct; 24(4):829-43, viii. PubMed ID: 16169448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of stimulants on a clinical measure of attention in children with ADHD.
    Gardner BK; Sheppard DM; Efron D
    Child Neuropsychol; 2008 Mar; 14(2):171-86. PubMed ID: 17852126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes.
    Stewman CG; Liebman C; Fink L; Sandella B
    Sports Health; 2018; 10(1):40-46. PubMed ID: 29144831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit/hyperactivity disorder in elite athletes: a narrative review.
    Han DH; McDuff D; Thompson D; Hitchcock ME; Reardon CL; Hainline B
    Br J Sports Med; 2019 Jun; 53(12):741-745. PubMed ID: 31097459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmethylphenidate for attention deficit hyperactivity disorder.
    Coury D
    Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
    Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-Deficit/Hyperactivity Disorder and Sports: A Lifespan Perspective.
    MacLean L; Prabhakar D
    Psychiatr Clin North Am; 2021 Sep; 44(3):419-430. PubMed ID: 34372998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.